Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Total Current Liabilities (2020 - 2025)

Healthcare Triangle filings provide 6 years of Total Current Liabilities readings, the most recent being $12.8 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 80.81% to $12.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.8 million, a 80.81% increase, with the full-year FY2025 number at $12.8 million, up 80.81% from a year prior.
  • Total Current Liabilities reached $12.8 million in Q4 2025 per HCTI's latest filing, up from $3.9 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $12.8 million in Q4 2025, with the low at $3.2 million in Q2 2025.
  • A 5-year average of $6.4 million and a median of $6.1 million in 2024 define the central range for Total Current Liabilities.
  • Peak annual rise in Total Current Liabilities hit 80.81% in 2025, while the deepest fall reached 48.78% in 2025.
  • Year by year, Total Current Liabilities stood at $6.3 million in 2021, then increased by 5.54% to $6.6 million in 2022, then rose by 23.57% to $8.2 million in 2023, then fell by 13.21% to $7.1 million in 2024, then soared by 80.81% to $12.8 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Total Current Liabilities are $12.8 million (Q4 2025), $3.9 million (Q3 2025), and $3.2 million (Q2 2025).